HSIC
Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET
Article Summary
BUY- Henry Schein Inc. (Nasdaq: HSIC) announced that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m.
- Henry Schein, the world's largest provider of healthcare solutions to office-based dental and medical practitioners, is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories, with sales reaching $13.2 billion in 2025 and growing at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
- With more than 25,000 Team Schein Members worldwide, Henry Schein's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 5.6% | 25% | 35.0 ptsBelow Screener (5.6%) - Weak growth |
| EPS Growth Next 5Y ? | 9.3% | 25% | 20.0 ptsWeak (9.3%) - Low expectations |
| Target Price Upside ? | 3.6% | 20% | 20.0 ptsMinimal Upside (3.6%) - Target: $88.81 vs Current: $85.76 |
| Gross Margin % ? | 29.2% | 15% | 40.0 ptsModerate (29.2%) - Adequate margins |
| Drawdown from 52-Wk High ? | -4.0% | 15% | 20.0 ptsBarely a Dip (-4.0%) - Near recent highs |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About HSIC
- Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
- It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
- The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services.
- It also markets and sells a portfolio of consumable merchandise under its own corporate brand.
- The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services.
- The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers.
- The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics.
- Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.